Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Obesity news topic | Rare Historical Photos

Nanexa Stock Skyrockets More Than 100% After Signing Drug Deal With Wegovy Maker Novo Nordisk

Under the deal, Novo gets the right to use PharmaShell in as many as five development programs for peptide-based medicines targeting obesity, type 2 diabetes and other cardiometabolic diseases.

International Business Times · Sep 25

Obesity and overweight cost European economies billions of euros a year, industry says

Obesity and overweight are costing European economies billions of euros every year, with the burden equivalent to what some countries spend on housing or defence, according to a pharmaceutical industry’s report.

Euronews · Sep 25

More Than a Third of 1.1 Million Adults Prescribed GLP-1s Without Documented Diabetes or Obesity Had Normal Weight

A study of more than 92 million health records found that 1.1 million adults got GLP-1 drugs without documented diabetes or obesity. What the data show and don't show.

Medical Daily · Sep 24

From analysis to the latest developments in health,
read the most diverse news in one place.

India takes battle against junk food to shops near schools

India is proposing regulations to ban the sale of unhealthy food within 50 metres of schools. This initiative aims to reduce rising obesity rates among children, which has increased significantly in recent years. Multinational companies are likely to feel the impact of these restrictions, as they may require recipe reformulations.…

The Economic Times · Sep 24

Viking's Obesity Edge May Be Staying Power, Not Weight Loss

Viking Therapeutics shares jumped 36% after VK2735 maintenance data showed patients kept most weight loss on less frequent dosing, though Phase 3 results and commercial funding remain unresolved.

MarketBeat · Sep 23

7 Signs Your Dieting Is Burning Muscle Instead of Fat and How to Stop Catabolism

Your Strength Drops Faster Than Your WeightThe most reliable early signal is not on the scale, it is on the barbell. If your bench press or squat numbers fall by 10 to 15 percent within two to three weeks of cutting calories hard, your body is almost certainly cannibalising muscle…

Times Life · Sep 23

5 Realities of Bariatric Surgery in India That Most Clinics Rarely Explain Upfront

The weight loss is real. The timeline they quote you is not.Most bariatric surgery brochures in India show a patient who has lost 30 to 40 kilograms in six months. What they don't show is that the rate of loss slows sharply after month three, and that the final number…

Times Life · Sep 22

Read news from The Economist, FT, and more,
with one subscription

GLP-1 Weight Loss Injections: How Semaglutide Works in the Body and Who Should Avoid Them

What GLP-1 Actually IsGlucagon-like peptide-1 is a hormone your small intestine already makes. It releases after you eat, signals the pancreas to produce insulin, slows how fast food leaves your stomach, and tells the brain's hypothalamus that you've had enough. GLP-1 receptor agonists, drugs like semaglutide (sold as Ozempic for…

Times Life · Sep 22

Why Slim Indians Often Carry Dangerous Visceral Fat and Face High Metabolic Risk

The Thin-Fat Indian Is Not a MythIn the late 1990s, Dr. C.S. Yajnik at the KEM Hospital in Pune made an observation that upended how researchers thought about Indian bodies. Indian newborns weighed less than British babies of European descent, yet carried significantly more body fat as a percentage of…

Times Life · Sep 22

Eli Lilly vs. Novo: The Obesity-Drug Battle Is Entering Its Next Round

The obesity drug market is moving to the second phase, and only one appears to be better positioned to lead the second wave.

Barchart · Sep 21

Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugs

Facing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating diversification into new therapy areas for sustainable growth. With Eli Lilly set to outshine its sales figures this year, analysts suggest a pivot towards developing zenagamtide instead of CagriSema. It is…

The Economic Times · Sep 21

6 Dangerous Things Visceral Fat Does Inside Your Organs That Belly Weight Never Reveals

It Turns Your Liver Into a Fat-Storage DepotVisceral fat is not stored passively. It sits wedged between your abdominal organs and releases free fatty acids directly into the portal vein, the blood vessel that feeds your liver. The liver receives this constant chemical signal and begins converting the excess into…

Times Life · Sep 21

Novo is Building a Strong Base to Address Unmet Needs in Diabetes and Obesity Drugs

Novo (formerly Novo Nordisk) is partnering with Anthropic to use AI to speed up drug discovery.

Barchart · Sep 18

Modak, Prasad and Festival Sweets Are Sending Indian Dogs to the Vet, Here Is Why

The biology that makes festival food dangerous for dogsDogs metabolise theobromine, the stimulant compound in cocoa, at roughly one-fifth the rate a human does. A 10-kilogram dog that eats 50 grams of dark chocolate barfi has consumed enough theobromine to trigger vomiting, muscle tremors, and cardiac arrhythmia. This is not…

Times Life · Sep 18

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Sep 18

Roughly 1 in 4 Fatty Liver Cirrhosis Cases Began Before 50, Tied to Genetics and Type 2 Diabetes

A UC San Diego-led study found that about 25% of fatty liver cirrhosis cases began before age 50, with genetics and type 2 diabetes as key factors.

The Conversation · Sep 14

One in six women may have this liver condition. What does it mean in pregnancy?

A liver condition that many people have never heard of may affect around one in six women of childbearing age worldwide. A 2025 global analysis estimated that 15.8% of women aged 15 to 49 were living with metabolic dysfunction-associated steatotic liver disease (MASLD) in 2021.

The Independent UK · Sep 14

UK overhauls school food rules to tackle child obesity

IN FULL

The Economic Times · Sep 12

Insurance company rejected Rs 3 lakh mediclaim saying it was an obesity treatment; court found the surgery also treats high BP, weight gain, knee pain; insurer ordered to pay Rs 3.5 lakh

An insurance company rejected a Rs 3.2 lakh mediclaim by calling a weight loss surgery an obesity treatment excluded under the policy. The Ernakulam consumer commission found the surgery was meant to treat high blood pressure, weight gain and knee problems together, and ruled that the insurer had no medical…

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation · Sep 10

Weight-loss campaigns aimed at First Nations women look like drug marketing in disguise

If you’ve scrolled through social media or watched TV, you’ve probably seen campaigns featuring women describing how difficult weight loss can be. These say you’ve probably “tried everything”. Then, viewers are encouraged to “talk to a doctor” about managing their weight.

Medical Daily · Sep 10

Weight Loss Drug Prescriptions for Children Aged Eight to Eleven Rose Sharply but Remain Rare Nationally

A new Pediatrics study found GLP-1 prescribing in children aged 8 to 11 rose 310-fold since 2019, though only 0.6 percent ever received one.

The Conversation · Sep 9

The weight-loss drug divide: private prescribing is lowest where need is greatest

For many people living with obesity, Wegovy and Mounjaro offer the possibility of substantial weight loss without surgery. Yet data from one private provider points to a troubling divide: prescription rates of these drugs in England are lowest in communities where obesity is most common.

Medical Daily · Sep 8

Semaglutide Was Linked to Nearly 40 Percent Fewer Asthma Attacks Across Four Parallel UK Records Analyses

UK health records link semaglutide to nearly 40% fewer asthma attacks. Researchers say the finding should not change treatment decisions yet.

Medical Daily · Sep 8

Semaglutide Users with Asthma Had Nearly 40 Percent Fewer Attacks in UK Records but Doctors Urge Caution

UK health records link semaglutide to nearly 40% fewer asthma attacks. The lead researcher says nobody should start it for their lungs.

Medical Daily · Sep 7

Weight Loss Shots Reach Children as Young as Eight in New National Data on Off-Label Prescribing

GLP-1 prescriptions for US children ages 8 to 11 with obesity rose 310-fold since 2019, a new Pediatrics study of 3.5 million kids finds.

The Guardian - UK · Sep 7

Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?

GLP-1 medications have been a gamechanger in the fight against obesity. But for a minority of patients, their impact is negligible. Why?

1 2 3 4 5

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.